Busque entre los 168782 recursos disponibles en el repositorio
Mostrar el registro sencillo del ítem
dc.date.accessioned | 2019-11-01T18:16:19Z | |
dc.date.available | 2019-11-01T18:16:19Z | |
dc.date.issued | 2002 | |
dc.identifier.uri | http://sedici.unlp.edu.ar/handle/10915/84674 | |
dc.description.abstract | This study evaluated the cellular immune response against Brucella species cytoplasmic protein (CP) in peripheral blood mononuclear cells (PBMC) of 25 patients with brucellosis. In vitro proliferation and cytokine gene expression and production were investigated. PBMC from 14 patients proliferated in response to CP (responder patients [RPs]) and cells from 11 patients did not (nonresponder patients [NRPs]). CP-specific interleukin (IL)-2 and interferon-γ were significantly induced in PBMC from RPs, compared with cells from NRPs. No significant differences were found in the production of IL-10 between the 2 groups. CP did not induce IL-4 production. A close relationship was observed between the clinical status of the patients and the T cell response against CP. Patient with acute infections responded to CP and induced production of T helper 1 (Th1) cytokines, whereas chronically infected patients did not. Diminished production of Th1 cytokines may contribute to T cell unresponsiveness in chronic human brucellosis. | en |
dc.format.extent | 252-259 | es |
dc.language | en | es |
dc.subject | Brucella | es |
dc.subject | cellular immune response | es |
dc.subject | human brucellosis | es |
dc.title | Diminished production of T helper 1 cytokines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis | en |
dc.type | Articulo | es |
sedici.identifier.other | doi:10.1086/341449 | es |
sedici.identifier.other | eid:2-s2.0-0037099241 | es |
sedici.identifier.issn | 0022-1899 | es |
sedici.creator.person | Giambartolomei, Guillermo H. | es |
sedici.creator.person | Delpino, M. Victoria | es |
sedici.creator.person | Cahanovich, Mariela E. | es |
sedici.creator.person | Wallach, Jorge C. | es |
sedici.creator.person | Baldi, Pablo C. | es |
sedici.creator.person | Velikovsky, Carlos A. | es |
sedici.creator.person | Fossati, Carlos Alberto | es |
sedici.subject.materias | Ciencias Exactas | es |
sedici.subject.materias | Ciencias Médicas | es |
sedici.description.fulltext | true | es |
mods.originInfo.place | Facultad de Ciencias Exactas | es |
sedici.subtype | Articulo | es |
sedici.rights.license | Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) | |
sedici.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | |
sedici.description.peerReview | peer-review | es |
sedici.relation.journalTitle | Journal of Infectious Diseases | es |
sedici.relation.journalVolumeAndIssue | vol. 186, no. 2 | es |
sedici.rights.sherpa | * RoMEO: verde* Pre-print del autor: can* Post-print del autor: can* Versión de editor/PDF:cannot* Condiciones:>>El pre-print sólo puede depositarse antes de la aceptación>>El pre-print debe acompañarse de una declaración establecida (ver enlace)>>El pre-print no debe reemplazarse por el post-print, sino que se enlazará a la versión publicada con una declaración establecida corregida>>Pre-print on author's personal website, employer website, free public server or pre-prints in subject area>>Post-print en el sitio web personal del autor de manera inmediata>>Post-print in Institutional repositories or Central repositories after 12 months embargo>>La versión de editor/PDF no puede utilizarse>>La fuente editorial debe reconocerse>>Debe ir enlazado a la versión de editor>>La copia archivada debe acompañarse de la frase establecida (ver Política)>>El editor depositará copia en PubMed Central en nombre de los autores financiados por el NIH>>Publisher last contacted on 19/02/2015* Link a Sherpa: http://sherpa.ac.uk/romeo/issn/0022-1899/es/ |